Rising Demand for AI Cancer Screening Puts Financial Burden on Patients
Thursday, 30 May 2024, 14:08
Rising Demand for AI Cancer Screening
The FDA has approved nearly 600 radiology AI programs since 2019, with the majority not covered by Medicare or private health insurance.
Financial Burden on Patients
- Costly Services: Patients are required to pay for advanced cancer screening out of pocket.
- Impact on Out-of-Pocket Expenses: The lack of insurance coverage increases the financial burden on individuals seeking these services.
The surge in AI cancer screening programs is reshaping the healthcare landscape.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.